SCYNEXIS Files 8-K on Shareholder Votes

Ticker: SCYX · Form: 8-K · Filed: Jun 20, 2024 · CIK: 1178253

Scynexis Inc 8-K Filing Summary
FieldDetail
CompanyScynexis Inc (SCYX)
Form Type8-K
Filed DateJun 20, 2024
Risk Levellow
Pages2
Reading Time3 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: SCYX

TL;DR

SCYNEXIS shareholders voted on something important, expect news soon.

AI Summary

SCYNEXIS, Inc. filed an 8-K on June 20, 2024, reporting on matters submitted to a vote of security holders as of June 19, 2024. The filing details the company's corporate structure and its principal executive offices located in Jersey City, New Jersey.

Why It Matters

This filing indicates that SCYNEXIS, Inc. has held or is holding a vote of its shareholders, which could lead to significant corporate decisions or changes.

Risk Assessment

Risk Level: low — This is a routine filing related to corporate governance and shareholder voting, not a direct financial event.

Key Players & Entities

  • SCYNEXIS, Inc. (company) — Registrant
  • June 19, 2024 (date) — Date of earliest event reported
  • June 20, 2024 (date) — Date of report
  • Jersey City, New Jersey (location) — Principal Executive Offices

FAQ

What specific matters were submitted to a vote of SCYNEXIS, Inc. security holders?

The filing does not specify the exact matters voted upon, only that it is a 'Submission of Matters to a Vote of Security Holders'.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on June 19, 2024.

What is the principal executive office address for SCYNEXIS, Inc.?

The principal executive offices are located at 1 Evertrust Plaza, 13th Floor, Jersey City, New Jersey 07302-6548.

What is the Commission File Number for SCYNEXIS, Inc.?

The Commission File Number for SCYNEXIS, Inc. is 001-36365.

Under which section of the Securities Exchange Act is this 8-K filed?

This 8-K is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Filing Stats: 713 words · 3 min read · ~2 pages · Grade level 10.9 · Accepted 2024-06-20 08:07:47

Key Financial Figures

  • $0.001 — ch registered Common Stock, par value $0.001 per share SCYX The Nasdaq Global Ma

Filing Documents

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On June 19, 2024, SCYNEXIS, Inc. held its 2024 Annual Meeting of Stockholders. The following is a brief description of each matter voted upon at the Annual Meeting, as well as the final tally of the number of votes cast: (a) for or withheld with respect to the election of directors; (b) for, against or abstain for the ratification of the appointment of Deloitte & Touche LLP as SCYNEXIS's independent registered public accounting firm for the fiscal year ending December 31, 2024; (c) for, against or abstain for the advisory approval of the executive compensation as disclosed in SCYNEXIS's proxy statement, filed with the Securities and Exchange Commission on April 25, 2024 (the "Proxy Statement"); and (d) for, against or abstain for the approval of the SCYNEXIS, Inc. 2024 Equity Incentive Plan. Broker non-votes are also reported. A more complete description of each matter is set forth in the Proxy Statement. Proposal 1: Each of the seven directors proposed by SCYNEXIS for re-election was elected to serve until SCYNEXIS's 2025 Annual Meeting of Stockholders or until his or her respective successor has been elected and qualified. The tabulation of votes on this matter was as follows: For Withheld Broker Non-Votes David Angulo, M.D. 14,952,407 508,995 10,498,371 Armando Anido 14,119,574 1,341,828 10,498,371 Steven C. Gilman, Ph.D. 14,027,862 1,433,540 10,498,371 Ann F. Hanham, Ph.D. 14,223,819 1,237,583 10,498,371 David Hastings 14,910,344 551,058 10,498,371 Guy Macdonald 14,830,674 630,728 10,498,371 Philippe Tinmouth 14,790,479 670,923 10,498,371 Proposal 2: The appointment of Deloitte & Touche LLP as SCYNEXIS's independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified. The tabulation of votes on this matter was as follows: For Against Abstain Broker Non-Votes 25,192,381 698,103

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SCYNEXIS, Inc. Date: June 19, 2024 By: /s/ David Angulo, M.D. Name: Its: David Angulo, M.D. Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.